-
-
-
-
-
-
-
Raymond James on Dianthus Therapeutics (DNTH) Amid 15% Down Day: 'We See Overall Positive Readthrough to Claseprubart'
-
-
-
-
-
-
-
William Blair Shuffles Analyst Conviction List for April 2026
-
-
-
-
-
-
-
Dianthus Therapeutics (DNTH) 1300 contracts of May 70 puts trade, share price up 19.3%
-
-
-
-
-
-
-
Clear Street on Dianthus Therapeutics (DNTH): 'We view these data as de-risking'
-
-
-
-
-
-
-
Dianthus Therapeutics (DNTH) PT Raised to $47 at H.C. Wainwright
-
-
-
-
-
-
-
Truist Securities Starts Dianthus Therapeutics (DNTH) at Buy
-
-
-
-
-
-
-
Cantor Fitzgerald Reiterates Overweight Rating on Dianthus Therapeutics (DNTH)
-
456,417 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

